Corrigendum to 'Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor': [EBioMedicine 54 (2020) 102719]
1 Department of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy; National Institute for Biostructures and Biosystems, Via delle Medaglie d'Oro 135, 00136 Rome, Italy.
2 Department of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy.
3 National Institute for Biostructures and Biosystems, Via delle Medaglie d'Oro 135, 00136 Rome, Italy.
4 Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center- IRCCS-, via Manzoni 56, 20089 Rozzano, Milan, Italy.
5 NGM Biopharmaceuticals Inc., 333 Oyster Point Blvd, South San Francisco, CA 94080, United States.
6 Department of Chemistry "Giacomo Ciamician", Alma Mater Studiorum, University of Bologna, Via Selmi, 2, 40126 Bologna, Italy.
7 Department of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy; National Cancer Center, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco, 65, 70124 Bari, Italy. Electronic address: antonio.moschetta@uniba.it.